Auriga Laboratories Obtains Rights To Market And Sell An FDA-Approved Product Indicated For The Treatment Of Mild To Moderately Severe Pain

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company building the first nationwide, commission-only pharmaceutical sales force, announced the signing of a manufacturing and supply agreement with Mikart, Inc., pursuant to which Auriga will have the exclusive rights to market and sell a new product indicated for the relief of mild to moderately severe pain in the United States. [click link for full article]

More: continued here

Filed under: Pain / Anesthetics on November 7th, 2007